Horizon Oncology Center
Lafayette, Indiana, United States
Oncologist in Lafayette, Indiana
1345 Unity Pl # 345, Lafayette, IN 47905
About Horizon Oncology Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoosier Cancer Research Network
8
National Cancer Institute (NCI)
5
Celgene
4
Hoffmann-La Roche
4
AVEO Pharmaceuticals, Inc.
3
Amgen
3
Endocyte
3
Merrimack Pharmaceuticals
3
Nasser Hanna, M.D.
3
Novartis Pharmaceuticals
3
Pfizer
3
Clinical Trials at Horizon Oncology Center
During the past decade, Horizon Oncology Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 41 clinical trials were completed, i.e. on
average, 157.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 15 clinical trials were completed. i.e. 214.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer
2007-01-01
2014-04-01
Completed
244
A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer
2005-09-01
2010-12-01
Terminated
80
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
2006-08-01
2008-12-01
Completed
25
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
2007-09-14
2017-03-21
Completed
361
Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes
2006-09-01
2008-12-01
Terminated
15
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Horizon Oncology Center" #1 sponsor was "Hoosier Cancer Research Network" with 8 trials, followed by "National Cancer Institute (NCI)" with 5 trials
sponsored, "Celgene" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "AVEO Pharmaceuticals, Inc."
with 4 trials sponsored. Other sponsors include 59 different institutions and
companies that sponsored additional 46 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Horizon Oncology Center"
#1 collaborator was "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Walther Cancer Institute" with 4 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator, "Hoosier Cancer Research Network" with 3 trials as a collaborator and "Indiana University School of Medicine" with 3 trials as a collaborator. Other collaborators include 41 different institutions and companies that were
collaborators in the rest 36 trials.
Clinical Trials Conditions at Horizon Oncology Center
According to Clinical.Site data, the most researched conditions in "Horizon Oncology Center" are
"Breast Cancer" (7 trials), "Solid Tumors" (7 trials), "Non-Small Cell Lung Cancer" (6 trials), "Multiple Myeloma" (5 trials) and "Ovarian Cancer" (4 trials). Many other conditions were trialed in "Horizon Oncology Center" in a lesser frequency.
Clinical Trials Intervention Types at Horizon Oncology Center
Most popular intervention types in "Horizon Oncology Center" are "Drug" (81 trials), "Other" (10 trials), "Biological" (8 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Bevacizumab" (6 trials), "Laboratory Biomarker Analysis" (6 trials), "Cyclophosphamide" (5 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Horizon Oncology Center
The vast majority of trials in "Horizon Oncology Center" are
78 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Horizon Oncology Center
Currently, there are NaN active trials in "Horizon Oncology Center".
undefined are not yet recruiting,
6 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 52 completed trials in Horizon Oncology Center,
undefined suspended trials,
and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Horizon Oncology Center, 46 "Phase 1"
clinical trials were conducted, 44 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".